PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING INFLAMMATION CAUSED BY ACANTHAMOEBA

WIPO Patent Application WO/2024/042930

A1

The purpose of the present invention is to provide a pharmaceutical composition and the like for treating or preventing inflammation caused by Acanthamoeba. Specifically provided are a pharmaceutical composition for treating or preventing inflammation caused by Acanthamoeba that contains a composite formed by joining lysozyme and chitosan, an antiprotozoal composition that contains a composite formed by joining lysozyme and chitosan, an anti-attachment agent for Acanthamoeba that contains a composite formed by joining lysozyme and chitosan, and the like.

JP2018162293	THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING THE SAME
JP7142286	Sugar chain-polypeptide complex containing selenium-containing amino acid, and its medical use
WO/2020/070675	SUSTAINED DELIVERY OF ANGIOPOETIN-LIKE 3 POLYPEPTIDES

KAJI YUICHI (JP)
TAKAHASHI NAOKO (JP)
KAGESHIMA HIROKI (JP)
HIRANO SHOUICHIROU (JP)

PCT/JP2023/026529

February 29, 2024

July 20, 2023

Click for automatic bibliography generation  

UNIV TSUKUBA (JP)
WAKO FILTER TECH CO LTD (JP)

A61K47/61; A61K31/722; A61K31/785; A61K33/40; A61K38/46; A61P27/02; A61P29/00; A61P33/04; A61P43/00

WO2017038872A1	2017-03-09
WO2017138476A1	2017-08-17
WO2020241681A1	2020-12-03

JPH04352728A	1992-12-07
JP2019077661A	2019-05-23
JP2007523362A	2007-08-16
JPH11255859A	1999-09-21

ANONYMOUS: " Disinfectant performance of soft contact lens disinfectants against Acanthamoeba - Based on actual usage survey -", NATIONAL CONSUMER AFFAIRS CENTER OF JAPAN, 16 December 2009 (2009-12-16), XP093139811

TANAKA Shinichiro et al. (JP)

View/Download PDF      PDF Help

Previous Patent: INFORMATION PROCESSING DEVICE AND IMAGE GENERATION METHOD

Next Patent: NONAQUEOUS ELECTROLYTE SECONDARY BATTERY